Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: CBD

AXIM Biotechnologies, Inc. and API Develop Marinol Alternative

AXIM Biotechnologies, Inc.

Medical marijuana has presented life-changing treatment options for patients around the world, but with strict laws in many regions preventing the use of such pharmaceutical alternatives, progress has been gradual. There is still significant stigma surrounding the effects of medical marijuana and its use in a clinical treatment setting. Despite the many positive studies associated with these products, opposition persists in many sectors of the market. Companies such as AXIM Biotechnologies, Inc. (OTCQX: AXIM) have long been at the forefront of medical marijuana research and development, facing opposition from lobbyists and other detractors who seek to keep the status quo within the pharmaceutical industry. Until recently, Insys Therapeutics was one of those companies.

In the past, Insys Therapeutics has been active in the opposition of general marijuana legalization, donating $500,000 to a group called Arizonans for Responsible Drug Policy in the summer of 2016. The group launched a campaign …

Continue Reading

Posted in Articles| Tagged , , , |

Medical Marijuana, Inc. Positioned Perfectly as New Studies Showcase How CBD Oil is Effective for Treating Epileptic Children

Medical Marijuana, Inc. (MJNA)

According to the Epilepsy Foundation, the incidence of epilepsy is highest in young children and older adults. There are currently 2.2 million people who are believed to have epilepsy in the United States alone, and many of those suffering are children whose symptoms prevent them from going to school and leading normal childhoods. Epileptic seizures can range from mild and infrequent to being characterized by violent and near-constant convulsions. The problem with many existing treatments for epilepsy is that they quite often come with debilitating side effects, are ineffective, or a combination of both. Children are even more severely affected by many of these negative side effects than adult patients, and their young age may limit the treatment options available to them.

Medical marijuana is an increasingly popular treatment option for children and adults with epilepsy. Around the world, there have been promising case studies on the positive effects …

Continue Reading

Posted in Articles| Tagged , , , |

ChineseInvestors.com to Attend ‘Invest 2017’ Exhibition in Stuttgart, Germany

SAN GABRIEL, California, April 5, 2017 /PRNewswire/ — ChineseInvestors.com (OTCQB: CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors, today announced that it will attend the ‘Invest 2017’ exhibition in Stuttgart, Germany which will take place on April 7-8, 2017. Invest 2017 is the leading trade fair and congress for finance and investment in Germany, and provides CIIX the opportunity to introduce its media and nutritional hemp companies, http://www.ChineseFN.com and http://www.ChineseCBDoil.com to German investors.

Invest 2017 is considered to be the No. 1 meeting point for the finance and investment sector in Germany. As one of the largest financial sector events in the Germany, it attracted more than 12,000 visitors and 144 exhibitors in 2016. Many private and institutional investors use the platform to obtain information, compare assets, and invest, while exhibitors have the opportunity to generate interest in raising investment capital for their ventures.

“I …

Continue Reading

Posted in Client News| Tagged , |

Bioequivalent Product to Marinol in the Works with AXIM Biotech at the Helm

AXIM Biotechnologies

In recent months, the medical benefits of cannabis have been all over the news. With reports that cannabis oil can reduce and even stop seizures, help patients with memory loss like dementia and Alzheimer’s, and even help to reduce pain associated with chronic illness, it makes sense that more and more biotech companies would be looking to get in on the market.

Earlier this week biotech newcomer AXIM Biotechnologies, Inc. (OTCQX: AXIM) announced that they would be teaming up with a United States based API (Active Pharmaceutical Ingredient) production company to further their production and creation of a dronabinol based functional chewing gum. AXIM is a forerunner in cannabinoid research and have been working for years to help develop solutions like Marinol, a gel capsule containing cannabinoid to help with things like nausea associated with AIDS treatment and chemotherapy.

About AXIM

AXIM has long been part of the cannabinoid …

Continue Reading

Posted in Articles| Tagged , , |

3-20-17 SmallCapVoice Interview with Chineseinvestors.com, Inc. (CIIX)

Chineseinvestors.com, Inc. (CIIX)

Alan Klitenic, Director for Investor Relations, ChineseInvestors.com, Inc. (CIIX), called in to SmallCapVoice.com, Inc. to go over the Company business model, markets it operates in and the recent news for the Company. Recently CIIX released Company’s financial and business achievements in January 2017, as well as offers insight into plans moving forward. This includes sequential revenue growth and the entrance into the hemp-based CBD oil industry.

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based CBD health products via its new website: www.ChineseCBDoil.com.

For more information visit www.ChineseInvestors.com
Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom
Follow us on Twitter for real-time company updates: https://twitter.com/ChineseFNEnglsh
Like us on Facebook to receive live feeds: …

Continue Reading

Posted in Interviews| Tagged , , |

HempMeds Continues Domestic and International Growth in 2017

MJNA

HempMeds is a subsidiary of Medical Marijuana, Inc. (MJNA), a publicly traded company that sells a variety of cannabis-based products in the United States and abroad. MJNA has made international headlines with its recent status as an exclusive importer of cannabidiol oil products to Brazil. In February of 2017, the Brazilian government approved a prescription for HempMeds’ Real Scientific Hemp Oil as a treatment for multiple sclerosis. Multiple sclerosis is a debilitating disease that affects the central nervous system, causing pain and a variety of other neuromuscular issues. With Real Scientific Hemp Oil, patients can experience the life-changing benefits of cannabidiol oil without the harmful side effects that accompany most pain medications.

The 2017 decision made by the Brazilian government’s National Health Surveillance Agency (ANVISA) is the first import approved for RSHO as a treatment for multiple sclerosis. More than 2.5 million people suffer from multiple sclerosis worldwide, which …

Continue Reading

Posted in Articles| Tagged , , , , |